Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012

• Pubblicazione: Washington : , : U.S. Government Printing Office, , 2013
• Descrizione fisica: 1 online resource (iv, 194 pages) : illustrations
• Soggetto topico: Drug approval - United States; Generic drugs - Government policy - United States; Biologicals - Government policy - United States; Drug accessibility - United States; Fees, Administrative - United States
• Note generali: Title from title screen (viewed on Aug. 14, 2013).; Paper version available for sale by the Superintendent of Documents, U.S. Government Printing Office.; "Serial no. 112-114."
• Nota di bibliografia: Includes bibliographical references.
• Altri titoli varianti: Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages
• Titolo autorizzato: Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910704729003321
• Lo trovi qui: Univ. Federico II